Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

Clene Inc. (CLNNW)

  • Business News
  • May 04, 2026, 12:00 UTC
  • 2
  • 1 comments

After Successful FDA Meeting, Clene Filing Accelerated Approval NDA for ALS

Market reaction Comment Full text

KEPPEL INFRASTRUCTURE FUND MANAGEMENT PTE LTD (A7RU)

  • SEC News
  • May 04, 2026, 12:00 UTC
  • 1
  • 0 comments

Interested Person Transaction: The Proposed Acquisition of an Additional 39% Interest in Keppel Merlimau Cogen Pte Ltd as an IPT

Comment Full text

BROADCOM INC. (AVGO)

  • Business News
  • May 04, 2026, 12:00 UTC
  • 0
  • 1 comments

Broadcom Inc. to Announce Second Quarter Fiscal Year 2026 Financial Results on Wednesday, June 3, 2026

Market reaction Comment Full text

EASTERLY GOVERNMENT PROPERTIES, INC. (DEA)

  • Business News
  • May 04, 2026, 12:00 UTC
  • 2
  • 1 comments

Easterly Government Properties to Participate in Wells Fargo 29th Annual Real Estate Securities Conference

Market reaction Comment Full text

EDGEWISE THERAPEUTICS, INC. (EWTX)

  • Business News
  • May 04, 2026, 12:00 UTC
  • 2
  • 1 comments

Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules

Market reaction Comment Full text

Johnson & Johnson (JNJ)

  • Business News
  • May 04, 2026, 12:00 UTC
  • 2
  • 1 comments

CAPLYTA® (lumateperone) showed greatest improvement across key efficacy outcomes among adjunctive MDD treatments in new network meta-analysis

Market reaction Comment Full text

AMC ENTERTAINMENT HOLDINGS, INC. (AMC)

  • Business News
  • May 04, 2026, 12:00 UTC
  • 2
  • 1 comments

More Than 4.4 Million Guests at AMC Theatres and ODEON Cinemas Affirm That Big Opening Weekends Are Staying in Fashion in 2026, as THE DEVIL WEARS PRADA 2 Scores a Reported $233 Million Worldwide to Kick off the “Summer Moviegoing Season”

Market reaction Comment Full text

Lineage Cell Therapeutics Inc. (LCTX)

  • Business News
  • May 04, 2026, 12:00 UTC
  • 2
  • 1 comments

OpRegen® 3 Year Results in Patients With GA Presented at Foundation Fighting Blindness Retinal Innovation Summit 2026

Market reaction Comment Full text

TAKEDA PHARMACEUTICAL CO LTD (TAK)

  • Business News
  • May 04, 2026, 12:00 UTC
  • 2
  • 1 comments

Takeda Announces Positive Topline Results from Pivotal Phase 2/3 Clinical Trial of TAK-881 in Primary Immunodeficiency Disease (PID)

Market reaction Comment Full text

GENIUS SPORTS LTD (GENI)

  • Business News
  • May 04, 2026, 12:00 UTC
  • 0
  • 1 comments

Genius Sports and Liga MX Strike Landmark Technology and AI Partnership to Drive Future of Mexican Soccer

Market reaction Comment Full text

CYPHER METAVERSE INC. (META)

  • Business News
  • May 04, 2026, 12:00 UTC
  • 2
  • 1 comments

JLens Urges Meta Shareholders to Vote FOR Proposal 8 at the Company’s Annual Meeting on May 27, 2026

Market reaction Comment Full text

WHEELS UP EXPERIENCE INC. (UP)

  • Business News
  • May 04, 2026, 12:00 UTC
  • 2
  • 1 comments

Wheels Up Announces Date of First Quarter 2026 Earnings Release

Market reaction Comment Full text

ASSERTIO HOLDINGS, INC. (ASRT)

  • Business News
  • May 04, 2026, 12:00 UTC
  • 2
  • 1 comments

Assertio Announces Amended and Restated Merger Agreement with Garda Therapeutics

Market reaction Comment Full text

TOAST, INC. (TOST)

  • Business News
  • May 04, 2026, 12:00 UTC
  • 2
  • 1 comments

Toast Announces New Alliance Partnership With Preferred Hotels & Resorts, The World’s Largest Independent Hotel Brand

Market reaction Comment Full text

SPRUCE BIOSCIENCES, INC. (SPRB)

  • Business News
  • May 04, 2026, 12:00 UTC
  • 2
  • 1 comments

Spruce Biosciences Further Strengthens its Commercial Leadership Team with the Appointments of Brian Walls as Vice President, Market Access and Darren Johnson as Vice President, Commercial Operations

Market reaction Comment Full text
  • Previous
  • 1040
  • 1041
  • 1042
  • 1043
  • 1044
  • Next

Search

News categories

  • Technical Exchange News(12380)
  • Event(6229)
  • SEC News(274032)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(158464)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin